PamGene, Nottingham University, CombiMatrix, Myriad Genetics, Korea Food and Drug Administration, Centre for Applied Genomics Microarray Facility, Invitrogen, University of Texas Southwestern Medical Center, Cepheid | GenomeWeb

PamGene Sells Nottingham University License for its 3D Microarray Platform

PamGene International of Den Bosch, The Netherlands, on Monday said that it has licensed its three-dimensional, flow-through microarray platform technology to Nottingham University in England.

According to the company, the service license includes the sale of a PamGene four-array PamStation and will allow the university to develop multiplex amplifiable probe hybridization as a service on the PamGene platform.

Financial terms of the licensing deal were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.